JOP20230043A1 - طرق لعلاج مرض قلبي وعائي باستخدام مركبات سيكلودكسترين - Google Patents
طرق لعلاج مرض قلبي وعائي باستخدام مركبات سيكلودكسترينInfo
- Publication number
- JOP20230043A1 JOP20230043A1 JOJO/P/2023/0043A JOP20230043A JOP20230043A1 JO P20230043 A1 JOP20230043 A1 JO P20230043A1 JO P20230043 A JOP20230043 A JO P20230043A JO P20230043 A1 JOP20230043 A1 JO P20230043A1
- Authority
- JO
- Jordan
- Prior art keywords
- disease
- effective amount
- atherosclerosis
- baseline
- increase
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
- A61K31/724—Cyclodextrins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Dermatology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063071257P | 2020-08-27 | 2020-08-27 | |
| PCT/US2021/048084 WO2022047249A1 (en) | 2020-08-27 | 2021-08-27 | Methods for the treatment of cardiovascular disease with cyclodextrins |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JOP20230043A1 true JOP20230043A1 (ar) | 2023-02-27 |
Family
ID=80353287
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JOJO/P/2023/0043A JOP20230043A1 (ar) | 2020-08-27 | 2023-02-27 | طرق لعلاج مرض قلبي وعائي باستخدام مركبات سيكلودكسترين |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US20240000826A1 (https=) |
| EP (1) | EP4203974A4 (https=) |
| JP (1) | JP2023543131A (https=) |
| KR (1) | KR20230104119A (https=) |
| CN (1) | CN116322644A (https=) |
| AU (1) | AU2021331487A1 (https=) |
| CA (1) | CA3189915A1 (https=) |
| CO (1) | CO2023003656A2 (https=) |
| CR (1) | CR20230135A (https=) |
| IL (1) | IL300805A (https=) |
| JO (1) | JOP20230043A1 (https=) |
| MX (1) | MX2023002418A (https=) |
| PE (1) | PE20231169A1 (https=) |
| WO (1) | WO2022047249A1 (https=) |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4877778A (en) * | 1987-07-01 | 1989-10-31 | The Children's Medical Center Corporation | Method of enhancing lipophile transport using cyclodextrin derivatives |
| MX371073B (es) * | 2012-04-13 | 2020-01-15 | L&F Res Llc | Método para utilizar ciclodextrina. |
-
2021
- 2021-08-27 US US18/023,325 patent/US20240000826A1/en active Pending
- 2021-08-27 EP EP21862882.4A patent/EP4203974A4/en active Pending
- 2021-08-27 AU AU2021331487A patent/AU2021331487A1/en not_active Abandoned
- 2021-08-27 CA CA3189915A patent/CA3189915A1/en active Pending
- 2021-08-27 KR KR1020237010388A patent/KR20230104119A/ko not_active Withdrawn
- 2021-08-27 JP JP2023513670A patent/JP2023543131A/ja active Pending
- 2021-08-27 CN CN202180053234.0A patent/CN116322644A/zh active Pending
- 2021-08-27 WO PCT/US2021/048084 patent/WO2022047249A1/en not_active Ceased
- 2021-08-27 CR CR20230135A patent/CR20230135A/es unknown
- 2021-08-27 IL IL300805A patent/IL300805A/en unknown
- 2021-08-27 MX MX2023002418A patent/MX2023002418A/es unknown
- 2021-08-27 PE PE2023000716A patent/PE20231169A1/es unknown
-
2022
- 2022-11-11 US US17/985,762 patent/US20230091966A1/en not_active Abandoned
-
2023
- 2023-02-27 JO JOJO/P/2023/0043A patent/JOP20230043A1/ar unknown
- 2023-03-23 CO CONC2023/0003656A patent/CO2023003656A2/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN116322644A (zh) | 2023-06-23 |
| EP4203974A1 (en) | 2023-07-05 |
| US20240000826A1 (en) | 2024-01-04 |
| CR20230135A (es) | 2023-07-19 |
| IL300805A (en) | 2023-04-01 |
| AU2021331487A1 (en) | 2023-03-16 |
| CO2023003656A2 (es) | 2023-08-09 |
| WO2022047249A1 (en) | 2022-03-03 |
| PE20231169A1 (es) | 2023-07-26 |
| EP4203974A4 (en) | 2024-08-07 |
| JP2023543131A (ja) | 2023-10-13 |
| US20230091966A1 (en) | 2023-03-23 |
| KR20230104119A (ko) | 2023-07-07 |
| CA3189915A1 (en) | 2022-03-03 |
| MX2023002418A (es) | 2023-07-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Christopoulos et al. | Application of the “hybrid approach” to chronic total occlusions in patients with previous coronary artery bypass graft surgery (from a Contemporary Multicenter US registry) | |
| Tayebjee et al. | Abnormal circulating levels of metalloprotease 9 and its tissue inhibitor 1 in angiographically proven peripheral arterial disease: relationship to disease severity | |
| JP2009536218A5 (https=) | ||
| JOP20230043A1 (ar) | طرق لعلاج مرض قلبي وعائي باستخدام مركبات سيكلودكسترين | |
| Jurasz et al. | Nonremodeling properties of matrix metalloproteinases: the platelet connection | |
| JOP20230130A1 (ar) | أحماض بيرازولو بيبريدين كربوكسيليك تحمل بدائل | |
| Ramesh et al. | Short-term safety and efficacy of escalating doses of atorvastatin for dyslipidemia in children with predialysis chronic kidney disease stage 2–5 | |
| Saedi et al. | Congenital atresia of left main coronary artery | |
| Bourdoumis et al. | Thromboprophylaxis and bleeding diathesis in minimally invasive stone surgery | |
| Yoo et al. | Fate of newly developed pulmonary embolism after surgery for renal cell carcinoma with vena cava thrombus | |
| Lee et al. | Vascular findings in CTA body and extremity of critically ill COVID-19 patients: commonly encountered vascular complications with review of literature | |
| Schachner et al. | Factors associated with presence of ascending aortic atherosclerosis in CABG patients | |
| Stolic et al. | The influence of atherosclerosis and plasma D-dimer concentration in patients with a functioning arteriovenous fistula for maintenance hemodialysis | |
| Ceyhun et al. | Relationship between whole blood viscosity and lesion severity in coronary artery disease | |
| Georgiou et al. | Beyond blood pressure: identifying factors associated with rapid kidney function decline in patients with CKD and coexisting COPD | |
| Gusdon et al. | Antithrombotic therapy for stroke patients with cardiovascular disease | |
| Elsayed et al. | Evaluation of different surgical modalities for coronary reconstruction of diffusely diseased left anterior descending artery | |
| Wu et al. | Intraoperative intra-aortic balloon pump improves 30-day outcomes of patients undergoing extensive coronary endarterectomy | |
| Green et al. | The heart in atherosclerotic renovascular disease | |
| Idrees | Pulmonary hypertension and leading factors in patients undergoing dialysis | |
| Reddy | Steps of atherosclerosis and its complication | |
| Khot et al. | From congenital variants to critical clues: A radiologic review of inferior vena cava pathologies | |
| Shirbi et al. | The Acute vs Chronic Post-CABG Complications: Does Gender Matter? A Retrospective Cohort Study from the Jordan University Hospital Records | |
| Schiffl | The dark side of high-intensity renal replacement therapy of acute kidney injury in critically ill patients | |
| Akella et al. | Coexisting portal vein thrombosis and aortic thrombosis in a patient with COVID-19: a case report and literature review |